Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07095829

Prognostic Model of Postnatal Circulation in Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum

Pulmonary atresia (PA)/critical stenosis (CS) with intact ventricular septum (PA/CS-IVS) is a rare congenital heart disease (CHD), that presents heterogeneously. Prognosis is conditioned by the possibility of achieving a primary repair with biventricular circulation (BV) or a one-and-a-half ventricle solution vs. a palliative approach bound to a univentricular (UV) circulation in which both survival and quality of life are significantly impaired. Predicting UV circulation prenatally is still a challenge.

The aim of this study is: 1/ to evaluate the natural history of the disease and develop a prognostic model for the prediction of transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age 2/ To develop a model to predict the risk of right ventricle dependent coronary circulation 3/ To evaluate prenatal and postnatal outcomes in non-intervened fetuses with a confirmed postnatal diagnosis of PA-CS/IVS including Intrauterine death, neonatal/Infant death, number of required postnatal procedures, need for oxygen support, need for cardiac transplantation

Recruiting

Interested in participating?

Request Info

Key information

Age range

16 week–28 week

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario 12 de Octubre, Madrid, Spain

Loading trial locations.

About this study

This is an international retrospective and prospective observational cohort study including non-intervened fetuses with a diagnosis of PA-CS/IVS between 16+0 and 28+6 weeks of gestation.

A baseline fetal ultrasound examination will be recorded for all included cases. The primary aim of the study is to develop a prognostic and validate model for the type of postnatal circulation (transplantation-free survival with a biventricular or a one-and-a-half repair at 2 years postnatal age vs univentricular palliation or transplanted).

In order to maximize the number of included cases in this rare entity, the model will be developed on retrospective data from 2013 until 2023 and validated in a prospective cohort. Cases will be recruited in referral centers regardless of their offering of fetal pulmonary valvuloplasty. However, only non-prenatally-intervened cases will be used for analysis. Fetal and postnatal echocardiographic examinations will be reviewed by a core laboratory to confirm eligibility for inclusion and identify potential measurement errors.

Data from at least one fetal echo (the first diagnostic evaluation at the referral center) and one postnatal (the first one performed after birth) will be collected, each containing a comprehensive set of two-dimensional and Doppler measurements. Additionally, one additional follow-up scan performed at least 8 weeks apart from the baseline diagnostic scan (ideally between 28 and 32 weeks) will be included in the study as well. Analysis of the prenatal change of dimensions of the right heart structures and selected hemodynamic parameters will enable comparisons between centers regardless of off-protocol center-specific postnatal treatment policies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Absence of flow at the pulmonary valve (PA) or presence of thickened and domed. pulmonary valve cusps with a pinhole jet of flow.
  • Doppler evidence of ductal-dependent pulmonary circulation.
  • Intact ventricular septum.

Exclusion criteria

  • Poor imaging windows and incomplete/poor quality scan
  • Termination of pregnancy
  • Cases initially included that undergo prenatal pulmonary valvuloplasty later on in pregnancy.
  • Unconfirmed PA-CS/IVS at birth.
  • Functional PA-CS/IVS (Ebstein malformation, monochorionic twins)
  • Any associated cardiac defect except persistent left superior vena cava and aberrant right subclavian artery.
  • Any significant (i.e that might influence outcome) extracardiac anomaly and/or known genetic syndromes. Also, if such a condition is present at inclusion but diagnosed only after birth, the case will be retrospectively excluded.

Treatment and study plan

No intervention

Other

Evaluation of natural history of the disease

Primary outcomes

  1. Prediction of postnatal circulation

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Transplantation-free survival with a non-univentricular circulation (biventricular or a one-and-a-half repair) at 2 years postnatal age: yes/no

Secondary outcomes

  1. Prediction of coronary circulation

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Prediction of right ventricle-dependent coronary circulation confirmed by cath or autopsy (yes/no)

  2. Intrauterine death

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Intrauterine death (yes/no)

  3. Neonatal/Infant death in the first 2 years

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Neonatal/Infant death in the first 2 years (yes/no)

  4. Number of required postnatal surgical and catheter interventional procedure

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Number of required postnatal surgical and catheter interventional procedures

  5. Type of required postnatal surgical and catheter interventional procedures

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Type of required postnatal surgical and catheter interventional procedures

  6. O2 saturation at 30 days (%)

    Time frame: 3 years (1 recruitment, 2 follow-up)

    O2 saturation at 30 days (%)

  7. Transplantation in the first two years

    Time frame: 3 years (1 recruitment, 2 follow-up)

    Transplantation in the first two years (yes/no)

Study contacts

Contact information is provided by the study sponsor or research team.

Alberto Galindo, MD PhD

CONTACT

[email protected]

+34913908310

Cecilia Villalain, MD PhD

CONTACT

[email protected]

+34913908310

Sponsors and collaborators

Lead sponsor

Hospital Universitario 12 de Octubre

Other

Collaborators

  • Instituto de Salud Carlos III
  • Instituto de investigación Hospital 12 de Octubre

Registry information

Official study title

Development and Validation of a Prognostic Model of Postnatal Circulation in Fetuses With a Diagnosis of Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum A Prospective Observational Cohort Study

Important dates

Study start
2024
Primary completion
2028
Study completion
2029
First posted
Jul 31, 2025
Registry last updated
Sep 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.